CoChat
Sign Up
Cited by 72

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis

Liu, Mengying, Bian, Chen, Zhang, Jiqiang, Wen, Feng·2014·Scientific Reports
DOI 10.1038/srep04383PMC PMC3955907
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep04383

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 47

  1. Selkoe, D. J. Alzheimer's disease: genes, proteins and therapy. Physiol Rev 81, 741–766 (2001). · DOI · Paper page
  2. Thies, W. & Bleiler, L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement 7, 208–244 (2011). · DOI
  3. Siest, G. et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 41, 1068–1086 (1995). · DOI · Paper page
  4. Levy-Lahad, E. & Bird, T. D. Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol 40, 829–840 (1996). · DOI
  5. Mahley, R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622–630 (1988). · DOI · Paper page
  6. Mahley, R. W. & Rall, S. C., Jr Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1, 507–537 (2000). · DOI · Paper page
  7. Morrow, J. A. et al. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry 39, 11657–11666 (2000). · DOI · Paper page
  8. Hauser, P. S. & Ryan, R. O. Impact of apolipoprotein E on Alzheimer's disease. Curr Alzheimer Res 10, 809–817 (2013). · DOI
  9. Millar, K., Nicoll, J. A., Thornhill, S., Murray, G. D. & Teasdale, G. M. Long term neuropsychological outcome after head injury: relation to APOE genotype. J Neurol Neurosurg Psychiatry 74, 1047–1052 (2003). · DOI
  10. Lahoz, C. et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154, 529–537 (2001). · DOI
  11. Verghese, P. B. et al. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci U S A 110, E1807–1816 (2013). · DOI · Paper page
  12. Claxton, A. et al. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. J Alzheimers Dis 35, 789–797 (2013). · DOI · Paper page
  13. Chen, D., Zhang, J. & Zhang, Z. Apolipoprotein E Gene Polymorphisms and Alzheimer's Disease. J G Genomics 30, 1167–1170 (2003).
  14. Zhang, Y., Liu, Z. & Du, Y. Association between Apolipoprotein E gene polymorphism and Vascular dementia and Alzheimer's disease. Shandong Med J 22, 1–2 (2004).
  15. Mai, Y., Luo, Y., Gu, H., Zhang, L. & LIN, J. Association between Interleukin-8 and Apolipoprotein E gene polymorphism and late-onset Alzheimer's disease. J sun yat-sen uni 1, 118–121 (2010).
  16. Jia, J., Zhang, J., Xu, M. & Zhou, W. Association between the apolipoprotein E gene polymorphism and the genetic sensitivity of sporadic Alzheimer's disease. Chin J Geriatrics 4, 7–9 (2002).
  17. Zhu, J., Xu, W. & Gao, Y. The association of apolipoprotein E and Alzheimer's disease. Practical Geriatrics 1, 23–25 (2000).
  18. Jiang, W., Lv, Z. & Tan, L. Correlation between apolipoprotein E gene polymorphism s and Alzheimer's disease and vascular dementia. J Clin Neurology 6, 408–410 (2010).
  19. He, S. R., Liu, D. G., Wang, S. & Xia, Y. J. Expression of apolipoprotein E in Alzheimer's disease and its significance. Chin J Pathology 34, 556–560 (2005).
  20. Zhou, C., Xu, J. & He, J. Genetic correlation study between apolipoprotein E gene and Alzheimer's disease. Med J NDFNC 4, 244–246 (2003).
  21. Huang, S., Lu, Y. & Chen, S. Inquiring relation between Apolipoprotein E Gene polymorphysm and the Alzheimer's disease. J M Clin Med Bio 1, 9–11 (2001).
  22. Li, G., Zhao, M., Zuo, L., Liu, F. & Kuang, S. Polymorphism in the Apolipoprotein E Gene and Its Association with Sporadic Alzheimer Disease. J Guiyang Med 1, 24–26 (2006).
  23. Bi, S. et al. The Relationship between ApoE Genotype, Serum Total Cholesterol Level and Alzheimer's disease. Chin J neuroimmunology 1, 13–16 (2002).
  24. Wu, P., Guo, Q., Chen, M., Zhou, Y. & Hong, Z. Relationship Between Apolipoprotein E Gene Polymorphism and Early-onset Alzheimer' s Disease. Chin J Clin Neurosci 3, 1168–1170 (2009).
  25. Zhou, C., Cheng, X. & Xia, X. Relationship between Apolipoprotein E Polymorphism and Alzheimer's Disease in Chongqing. J Chin GP 27, 3115–3117 (2012).
  26. Yang, J., Yu, F. & Wang, Y. Study of the polymorphisms of APOE gene in Alzheimer's disease and vascular dementia. Neuro Dis Mental H 2, 138–140 (2008).
  27. Dong, X. The study of the relationship between AD and the ApoE polymorphism. Chin H Care Nutrition 2, 523–524 (2013).
  28. Yang, L. Study on the association between Apolipoprotein E gene polymorphisms and sporadic Alzheimer's disease. Chin Mod Doctor 24, 89–90 (2008).
  29. Duan, G., Guo, L. & Yang, L. Study on the Association of Apolipoprotein E-gene Polymorphism with Demented Patients. J Henan Med C 6, 559–561 (2009).
  30. Lv, X. & Zhong, Y. Study on the relationship between apolipoprotein E gene polymorphism and mild cognitive impairment and Alzheimer's disease. Chin J Gerontology 5, 917–919 (2012).
  31. Huang, H. M., Kuo, Y. M., Ou, H. C., Lin, C. C. & Chuo, L. J. Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population. J Neural Transm 109, 1415–1421 (2002). · DOI
  32. Wang, H. K. et al. Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia. J Neural Transm 113, 1499–1509 (2006). · DOI
  33. Saunders, A. M. et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467–1472 (1993). · DOI · Paper page
  34. Schmechel, D. E. et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90, 9649–9653 (1993). · DOI · Paper page
  35. Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90, 1977–1981 (1993). · DOI · Paper page
  36. Rhinn, H. et al. Integrative genomics identifies APOE epsilon4 effectors in Alzheimer's disease. Nature 500, 45–50 (2013). · DOI
  37. Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16, 903–907 (2011). · DOI · Paper page
  38. Ward, A. et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology 38, 1–17 (2012). · DOI · Paper page
  39. Hostage, C. A., Roy Choudhury, K., Doraiswamy, P. M., Petrella, J. R. & Alzheimer's Disease Neuroimaging, I. Dissecting the gene dose-effects of the APOE epsilon4 and epsilon2 alleles on hippocampal volumes in aging and Alzheimer's disease. PLoS One 8, e54483 (2013). · DOI
  40. Pomara, N. & Bruno, D. Potential effects of the APOE epsilon2 allele and of family history of Alzheimer's disease on brain amyloid-beta in normal elderly. Proc Natl Acad Sci U S A 108, E1007; author reply E1008 (2011). · DOI
  41. Jofre-Monseny, L., Minihane, A. M. & Rimbach, G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52, 131–145 (2008). · DOI
  42. Smith, J. D. Apolipoproteins and aging: emerging mechanisms. Ageing Res Rev 1, 345–365 (2002). · DOI
  43. Jack, C. R., Jr et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132, 1355–1365 (2009). · DOI · Paper page
  44. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939–944 (1984). · DOI · Paper page
  45. Kim, S. M. et al. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology 55, 25–34 (2013). · DOI
  46. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177–188 (1986). · DOI · Paper page
  47. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719–748 (1959).

Cited by

Sorted by citations

See all 72

Metadata

Authors
Liu, M., Bian, C., Zhang, J., & Wen, F.
Venue
Scientific Reports
Publisher
Springer Science and Business Media LLC
Published
2014-03-17
Volume
4
Issue
1
ISSN
2045-2322
DOI
10.1038/srep04383
PMC
PMC3955907
Cited by
72
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review